Christine Lovly Archives
Endowed fellowships help create personal connections
May. 12, 2016—When former Nashvillian Carol O’Hare speaks about a specific group of physicians at Vanderbilt-Ingram Cancer Center (VICC), her voice softens, and she refers to them affectionately as “my fellows.”
Lovly lands cancer research grant from V Foundation
Jan. 21, 2016—Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been awarded a V Scholar Grant from the V Foundation for Cancer Research.
VICC helps expand cancer patient’s treatment options
Jan. 14, 2016—Edward (Ned) Wikle recently celebrated the Christmas holidays with his wife and three young children, a celebration the Jackson, Mississippi-based endodontist, U.S. Navy veteran and cancer patient wasn’t sure he would have.
Gene mutations may predict melanoma response to immunotherapies
Mar. 12, 2015—Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators.
Lung cancer study reveals new drug combination targets
Sep. 4, 2014—A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.
Lovly’s research bolstered by lung cancer foundation
Jul. 17, 2014—The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology.
Twelfth annual Vanderbilt Research Retreat set for Oct. 4
Sep. 24, 2013—The Vanderbilt community is invited to attend the 12th annual Research Retreat, a showcase of cutting-edge biomedical science by Vanderbilt faculty members and trainees.
Lovly lands Damon Runyon cancer research award
Jul. 11, 2013—Christine Lovly, M.D., Ph.D., assistant professor of Medicine, has received the 2013 Damon Runyon Clinical Investigator Award, which supports young physician-scientists conducting patient-oriented cancer research.
